Amoxicillin concentrations in relation to beta-lactamase activity in sputum during exacerbations of chronic obstructive pulmonary disease

References

• RabeKFHurdSAnzuetoAGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med200717653255517507545
   PubMed Web of Science ®Google Scholar
• CelliBRBarnesPJExacerbations of chronic obstructive pulmonary diseaseEur Respir J2007291224123817540785
   PubMed Web of Science ®Google Scholar
• SeemungalTADonaldsonGCPaulEABestallJCJeffriesDJWedzichaJAEffect of exacerbation on quality of life in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1998157141814229603117
   PubMed Web of Science ®Google Scholar
• DonaldsonGCSeemungalTABhowmikAWedzichaJARelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax20025784785212324669
   PubMed Web of Science ®Google Scholar
• WilsonRBacterial infection and chronic obstructive pulmonary diseaseEur Respir J19991323323510065660
   PubMed Web of Science ®Google Scholar
• HirschmannJVDo bacteria cause exacerbations of COPD?Chest200011819320310893379
   PubMed Web of Science ®Google Scholar
• HirschmannJVBacteria and COPD exacerbations reduxChest200111966366711171760
   PubMed Web of Science ®Google Scholar
• QuonBSGanWQSinDDContemporary management of acute exacerbations of COPD: a systematic review and metaanalysisChest200813375676618321904
   PubMed Web of Science ®Google Scholar
• NiewoehnerDEErblandMLDeupreeRHEffect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study GroupN Engl J Med19993401941194710379017
   PubMed Web of Science ®Google Scholar
• DaviesLAngusRMCalverleyPMOral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trialLancet199935445646010465169
   PubMed Web of Science ®Google Scholar
• MaltaisFOstinelliJBourbeauJComparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trialAm J Respir Crit Care Med200216569870311874817
   PubMed Web of Science ®Google Scholar
• LlorCMoragasAHernandezSBayonaCMiravitllesMEfficacy of antibiotic therapy for acute exacerbations of mild to moderate chronic obstructive pulmonary diseaseAm J Respir Crit Care Med201218671672322923662
   PubMed Web of Science ®Google Scholar
• DanielsJMSnijdersDde GraaffCSVlaspolderFJansenHMBoersmaWGAntibiotics in addition to systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med201018115015719875685
   PubMed Web of Science ®Google Scholar
• BaldwinDRHoneybourneDWiseRPulmonary disposition of antimicrobial agents: methodological considerationsAntimicrob Agents Chemother199236117111751416816
   PubMed Web of Science ®Google Scholar
• GouldIMHarveyGGolderDPenetration of amoxycillin/clavulanic acid into bronchial mucosa with different dosing regimensThorax19944999910017974318
   PubMed Web of Science ®Google Scholar
• DaviesBMaesenFSerum and sputum antibiotic levels after ampicillin, amoxycillin and bacampicillin chronic bronchitis patientsInfection19797Suppl 5S465S468315930
   PubMed Web of Science ®Google Scholar
• Brusse-KeizerMten BokumLMovigKRelation between amoxicillin concentration in sputum of COPD patients and length of hospitalizationCOPD20118667021495834
   PubMedGoogle Scholar
• PenningtonJEPenetration of antibiotics into respiratory secretionsRev Infect Dis1981367737013001
   PubMedGoogle Scholar
• SportelJHKoëterGHvan AltenaRLöwenbergABoersmaWGRelation between beta-lactamase producing bacteria and patient characteristics in chronic obstructive pulmonary disease (COPD)Thorax1995502492537660337
   PubMed Web of Science ®Google Scholar
• BarcelonaLMarinMStamboulianDBetalactam antibiotics combined with bectalactamases inhibitors. Amoxicillin-sulbactamMedicina (B Aires)2008686574 Spanish18416324
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung DiseaseGlobal Strategy for the Diagnosis, Management and Prevention of COPD2011 Available from: http://www.goldcopd.org/Accessed October 9, 2014
   Google Scholar
• Rodriguez-RoisinRToward a consensus definition for COPD exacerbationsChest2000117398S401S10843984
   PubMed Web of Science ®Google Scholar
• LoveringAMPycockCJHarveyJEReevesDSThe pharmacokinetics and sputum penetration of ampicillin and amoxycillin following simultaneous iv administrationJ Antimicrob Chemother1990253853922338417
   PubMed Web of Science ®Google Scholar
• European Committee for Antimicrobial Susceptibility TestingMIC determination2014 Available from: http://www.eucast.org/antimicrobial_susceptibility_testing/qc_tablesAccessed December 1, 2014
   Google Scholar
• BraudeACCohenRDPennerJLPrestonMARebuckASPulmonary disposition of moxalactamChest1984868818836499551
   PubMed Web of Science ®Google Scholar
• Bergogne-BerezinEPenetration of antibiotics into the respiratory treeJ Antimicrob Chemother198181711747287601
   PubMed Web of Science ®Google Scholar
• HoneybourneDAntibiotic penetration into lung tissuesThorax1994491041068128396
   PubMed Web of Science ®Google Scholar
• BaldwinDRHoneybourneDWiseRPulmonary disposition of antimicrobial agents: in vivo observations and clinical relevanceAntimicrob Agents Chemother201136117611801416817
   PubMed Web of Science ®Google Scholar
• StockleyRAHillSLBurnettDNebulized amoxicillin in chronic purulent bronchiectasisClin Ther201175935994053147
   PubMed Web of Science ®Google Scholar
• HillSLMorrisonHMBurnettDStockleyRAShort term response of patients with bronchiectasis to treatment with amoxycillin given in standard or high doses orally or by inhalationThorax1986415595653787536
   PubMed Web of Science ®Google Scholar
• FraschiniFScaglioneFFalchiMPharmacokinetics and tissue distribution of amoxicillin plus clavulanic acid after oral administration in manJ Chemother199021711772199627
   PubMed Web of Science ®Google Scholar
• MaesenFPDaviesBIBaurCAmoxycillin/clavulanate in acute purulent exacerbations of chronic bronchitisJ Antimicrob Chemother1987193733833494724
   PubMed Web of Science ®Google Scholar
• HavardCWFernandoABrumfittWHamilton-MillerJMA pilot study of ‘Augmentin’ in lower respiratory tract infections: pharmacokinetic and clinical resultsBr J Dis Chest1982762552606751365
   PubMedGoogle Scholar
• IngoldASputum and serum levels of amoxycillin in chronic bronchial infectionsBr J Dis Chest1975692112161201187
   PubMedGoogle Scholar
• LoveringAMPycockCJHarveyJEReevesDSThe pharmacokinetics and sputum penetration of ampicillin and amoxycillin following simultaneous iv administrationJ Antimicrob Chemother1990253853922338417
   PubMed Web of Science ®Google Scholar
• HillSLBurnettDLoveringALStockleyRAUse of an enzyme-linked immunosorbent assay to assess penetration of amoxicillin into lung secretionsAntimicrob Agents Chemother199236154515521510453
   PubMed Web of Science ®Google Scholar
• BathoornELieskerJPostmaDKoëterGvan OosterhoutAJKerstjensHASafety of sputum induction during exacerbations of COPDChest200713143243817296644
   PubMed Web of Science ®Google Scholar